| Mr Francois G Kleynhans, | |
|
189 Niblick Rd, Paso Robles, CA 93446-4845 | |
| (805) 237-1803 | |
| Not Available |
| Full Name | Mr Francois G Kleynhans |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 189 Niblick Rd, Paso Robles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760874945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 56565 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Francois G Kleynhans, 189 Niblick Rd, Paso Robles, CA 93446-4845 Ph: (805) 237-1803 | Mr Francois G Kleynhans, 189 Niblick Rd, Paso Robles, CA 93446-4845 Ph: (805) 237-1803 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
Smokers with diminished chest muscle may face a greater risk of death than those smokers with more chest muscle, whether they have chronic obstructive pulmonary disease (COPD) or not, according to new research presented at the ATS 2017 International Conference.
Catheter Connections, Inc., a manufacturer of innovative vascular access and infection control products, today announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its DualCap™ product. DualCap is the only device that nests two disinfecting caps together - for both IV access points, the needleless injection site (NIS) and the male luer at the end of the IV tubing. Previously overlooked as a route of microbial colonization, Catheter Connections has developed the first disinfecting cap for the male luer.
A new study has shown that women may have a better memory for words than men in the early stages of Alzheimer's disease, despite evidence of similar levels of shrinkage in the brain area responsible for verbal memory.
On the front lines of our defenses against bacteria is the protein calprotectin, which "starves" invading pathogens of metal nutrients. Vanderbilt investigators now report new insights to the workings of calprotectin - including a detailed structural view of how it binds the metal manganese.
› Verified 2 days ago
Mrs. Maria C De Nysschen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2424 Spring St, Paso Robles, CA 93446 Phone: 805-239-3208 Fax: 805-239-1878 | |
Abigail Victoria Joy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 | |
Sarah Elizabeth Stafford, BPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 Fax: 805-238-3251 | |
Ms. Minakshi Gurbhele, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 | |
David Bircher, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 Fax: 805-238-3251 | |
Kellie Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2424 Spring St, Paso Robles, CA 93446 Phone: 805-239-3208 Fax: 805-239-1878 | |
Stuart Wensil, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 189 Niblick Rd, Paso Robles, CA 93446 Phone: 805-237-1803 Fax: 805-237-8768 |